Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Automated Microbial Testing Markets --- Aarkstore Enterprise

Posted Nov 17 2010 11:05am

 Microorganisms are ubiquitous and may be found in almost every environment on earth. As such, they are a diverse group with an assortment of genotypic and phenotypic features and varying growth and reproduction requirements. There is continual interaction between humans and microbes, ranging from disease-causing pathogenic organisms invading the human body to microorganisms harnessed by humans to aid in the fermentation of food products. The detection and characterization of these organisms enables us to better understand how to manipulate and exert some control over their impact on our lives and welfare. This TriMark Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as the diagnostic microbiology and focuses primarily on the automated microbial testing systems. Within medical diagnostics, automated microbial testing for infectious disease-causing organisms offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--as well as the development of microarray devices--have led the microbiology market to accept the power of advanced analytical techniques for the diagnosis and treatment of infectious disease. For this analysis, the automated microbial testing market has been divided into the following segments for this examination: 1) microbial detection, 2) microbial enumeration, 3) microbial identification and 4) detection of antibiotic resistance. This report analyzes the size and growth of the automated microbial testing market in its applications for infectious disease detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the U.S. and worldwide.


Table of Contents :

1. Overview
1.1 Statement of Report
1.2 About this Report
1.3 Scope of the Report
1.4 Objectives
1.5 Methodology
1.6 Executive Summary
2. Introduction to Automated Microbial Testing
2.1 Limitations of Standard Culturing Techniques
2.2 Advantages of Automated Microbial Testing
2.3 Objectives of Automated Microbial Testing Systems

2.3.1 Microbial Detection
2.3.2 Microbial Quantitation
2.3.3 Microbial Identification
2.3.4 Detection of Antibiotic Resistance

2.4 Specimen Processing/Preparation
3. Automated Microbial Testing Market
3.1 Market Overview-A Business Case for Automated Microbial Testing
3.2 Clinical Diagnostics Market

3.2.1 Major Market Segments

3.2.1.1 Hospital Market
3.2.1.2 Independent Clinical Laboratory Market
3.2.1.3 Public Health Laboratory Market
3.2.1.4 Blood Banks

3.2.2 Overview of Clinical Specimen Types

3.2.2.1 Importance of Specimen Collection and Transport

3.2.3 Sales Projections of Major Clinical Applications

3.2.3.1 Blood Culture
3.2.3.2 Urine Screening
3.2.3.3 Microbial Identification and Antibiotic Susceptibility

3.3 Industrial Microbiology Market

3.3.1 Food Testing Market
3.3.2 Pharmaceutical Testing Market
3.3.3 Biodefense and Water Monitoring Market

3.4 Competitive Landscape and Market Share Analysis of Automated Microbiology Products
3.5 Global Market Analysis
4. Technology Platforms and Industry Players
4.1 Instrumentation Review

4.1.1 Automated Cell Culturing
4.1.2 Automated Biochemical Assays
4.1.3 Automated Genetic-based Assays
4.1.4 Automated Immunological Assays

5. Important Trends Affecting Automated Microbial Detection
5.1 Increase in Antibiotic Resistance
5.2 Influenza and Other Infectious Diseases
5.3 Concerns about Food and Drug Safety
5.4 Security against Bioterrorism
5.5 Regulatory Landscape
5.6 Business Landscape

5.6.1 Technology and Market Trends

5.6.1.1 Technology Trends
5.6.1.2 Specific New Instrument Opportunities

5.6.2 Potential Market Entry Barriers and Risks
5.6.3 Alternative Market Penetration Strategies
5.6.4 Business Planning Issues and Concerns

5.6.4.1 M&A Activity

5.6.5 Partnering
5.6.6 Competitive Situation

5.6.6.1 Primary Competitors
5.6.6.2 Industry Challenges and Strategic Recommendations
5.6.6.3 Commercialization of Automated Microbial Testing Products

5.6.7 Intellectual Property Rights

5.7 New Opportunities and Strategic Recommendations

5.7.1 Specific Opportunities for Automated Instrumentation Systems with Significant Market Appeal During the Next Five Years
5.7.2 Developments for Microbial Sensitivity Instrumentation Products
5.7.3 Market Penetration Strategies for Microbial Susceptibility Testing
5.7.4 Automated Microbial Testing Sector Commercial Developments

6. Company Profiles
6.1 Abbott Laboratories
6.2 AES Chemunex
6.3 Advanced Analytical Technologies, Inc.
6.4 Applied Biosystems (Part of Life Technologies Corporation)
6.5 Becton Dickinson and Company
6.6 bioMerieux
6.7 Celsis International plc
6.8 Cepheid
6.9 Dupont Qualicon
6.10 Eiken Chemical Co., Ltd.
6.11 Gen-Probe, Inc.
6.12 Giles Scientific
6.13 Lonza Group Ltd.
6.14 3M
6.15 Merlin Diagnostika GmbH
6.16 MIDI, Inc.
6.17 Millipore Corp.
6.18 Pall Corporation
6.19 PDS
6.20 Roche Ltd.
6.21 Siemens Healthcare Diagnostics
6.22 TREK Diagnostic Systems (Part of Magellan Biosciences, Inc.)
INDEX OF FIGURES
Figure 3.1: World Market for Treatments of Infectious Diseases, 2008-2014
Figure 3.2: Global Microbiology Market by Region, 2009
Figure 3.3: Microbiology Market by Sector, 2003-2013
Figure 3.4: Molecular Diagnostics Market Segmentation
Figure 3.5: U.S. Lab Market Share by Test Volume, 2009
Figure 3.6: Percentage of Clinical Samples Containing Pathogens by Specimen Type
Figure 3.7: Total Micro Testing Process Flow Chart
Figure 3.8: Rapid and Traditional Industrial Microbiology Testing Volume, 2003-2013
Figure 3.9: Rapid and Traditional Industrial Microbiology Testing as Percentage of Total, 2003-2013
Figure 3.10: Food Microbiology Testing Sample Collection Points
Figure 3.11: Microbiology Test Volume in the Food Industry, 2005-2013
Figure 3.12: Percentage of Pharmaceutical Manufacturers Using Rapid
Microbiological Methods
Figure 3.13: Flowchart of Steps for Implementation of Rapid Microbial Methods
Figure 3.14: Clinical Bacteriology Market Size by Region
Figure 3.15: Industrial Applications Market by Region
Figure 5.1: Incidence Rates of Infectious MRSA Infections by Age
Figure 5.2: Global Frequency of Vancomycin-resistant Enterococcus, 2006
Figure 5.3: Number of Reported and Confirmed Cases of Influenza H1N1 Strain Worldwide, 2009
Figure 5.4: Status of H5N1 Avian Influenza, 2009
Figure 5.5: Global Trend of HIV Infection, 1991-2007
INDEX OF TABLES
Table 3.1: Global Microbiology Market Size, 2003-2015
Table 3.2: Automated Microbial Testing Market Segments Overview
Table 3.3: Global Microbiology Market by Operational Sector, 2003-2013
Table 3.4: Medical Instrument Automation Technologies Market: Diagnostic Applications, 2003-2015
Table 3.5: Key Drivers in the Automated Microbial Testing Market
Table 3.6: Key Barriers to the Automated Microbial Testing Market
Table 3.7: Global Clinical In Vitro Diagnostics Markets by Assay Type
Table 3.8: Clinical Bacteriology Market Size by Testing Method
Table 3.9: Global Market for Detection of Infectious Diseases Using Molecular Diagnostic Methods, 2006-2015
Table 3.10: Share of Molecular Diagnostics Market Size Testing by Type
Table 3.11: Global Market for Blood-Screening Diagnostic Testing, 2000-2009
Table 3.12: U.S. Market for Blood-Screening Diagnostic Testing, 2000-2009
Table 3.13: Overview of Specimens for Culture
Table 3.14: Global Urinalysis Market
Table 3.15: Global Microbiology ID/AST Market, 2002-2009
Table 3.16: Global Market Segments Performing Microbiology Tests by Test Volume
Table 3.17: Global Food Microbiology Market, 2005-2013
Table 3.18: Traditional and Rapid Microbiology Testing in the Food Industry, 2005-2013
Table 3.19: RMM in Pharmaceutical Testing Market by Type
Table 3.20: U.S. Market for Biological Threat Detection Testing, 2000-2010
Table 3.21: Microbiology Market Share Profile, 2009
Table 3.22: ID/AST Market Share Profile, 2009
Table 3.23: Global IVD Growth Rates, 2009-2014
Table 4.1: Automated Cell Culturing
Table 4.2: Automated Biochemical Assays
Table 4.3: Automated Genetic-based Assays
Table 4.4: Automated Immunological Assays
Table 5.1: Major Pathogens Identified in the Last 30 Years
Table 5.2: Global Market Potential for TB Diagnostic Testing, 2000-2010
Table 5.3 Key Regulatory Requirements for Microbial Testing Instruments and Reagents
Table 5.4 Drivers of the Microbial Testing Market
Table 5.5: Technology Trends in Microbial Susceptibility Testing
Table 5.6: Market Trends in Microbial Susceptibility Testing
Table 5.7 Microbial Testing Markets: Market Drivers Ranked in Order of Impact
Table 5.8 Microbial Testing Markets: Market Restraints Ranked in Order of Impact
Table 5.9: Companies that Offer Products for Automated Microbial Testing
Table 5.10: Competitive Factors in the Automated Microbial Testing Diagnostics Infectious Disease Market
Table 5.11: Infectious Disease Testing Market: Strategic Recommendations on Sector Business Functions
Table 5.12: Automated Microbial Testing Market: Impact of Top Industry Challenges (U.S.)
Table 6.1: Products Marketed by Abbott in the Diagnostic Market

For more information, please visit : http://www.aarkstore.com/reports/Automated-Microbial-Testing-Markets-62476.html

Contact :Sanaa

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Post a comment
Write a comment:

Related Searches